TVARDI THERAPEUTICS
Tvardi Therapeutics they are focused on the development of orally delivered, small molecule inhibitors of STAT3. They provide medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases.
TVARDI THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Service Industry
Founded:
2017-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.tvarditherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
832-413-1362
Total Funding:
81.42 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Maps LetsEncrypt SSL By Default
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Koya Medical
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
683 CAPITAL
683 CAPITAL investment in Series B - Tvardi Therapeutics
Slate Path Capital
Slate Path Capital investment in Series B - Tvardi Therapeutics
Sporos Bioventures
Sporos Bioventures investment in Series B - Tvardi Therapeutics
ArrowMark Partners
ArrowMark Partners investment in Series B - Tvardi Therapeutics
Piedmont Capital Investments
Piedmont Capital Investments investment in Series B - Tvardi Therapeutics
THE CATALYTIC IMPACT FOUNDATION (CIF)
THE CATALYTIC IMPACT FOUNDATION (CIF) investment in Series B - Tvardi Therapeutics
Official Site Inspections
http://www.tvarditherapeutics.com Semrush global rank: 16.19 M Semrush visits lastest month: 1
- Host name: secure.depinhodesign.com
- IP address: 104.247.77.142
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Tvardi Therapeutics"
Company Overview - Tvardi Therapeutics
Tvardi Therapeutics is a clinical stage, biotechnology company developing a new class of breakthrough medicines for fibrosis-driven diseases. Founded in 2017 …See details»
Tvardi Therapeutics | Home | IPF Clinical Trials
Tvardi Therapeutics is a clinical-stage, biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need.See details»
Leadership Team - Tvardi Therapeutics
Kari Anne Rowland, M.S. brings twenty years of industry and life sciences experience mostly dedicated to clinical stage development of biological and small molecule therapeutics across …See details»
Cara Therapeutics and Tvardi Therapeutics Announce Entry into …
Dec 18, 2024 Management and Organization: Following the Merger, the combined company will be headquartered in Houston, Texas and will be led by Tvardi’s CEO, Imran Alibhai, Ph.D., …See details»
Tvardi Therapeutics (TVRD) Company Profile & Description - Stock …
Apr 16, 2025 Company profile for Tvardi Therapeutics, Inc. (TVRD) stock, with a description, list of executives, contact details and other key facts.See details»
Tvardi Therapeutics, Inc. Company Profile | Sugar Land, TX ...
Find company research, competitor information, contact details & financial data for Tvardi Therapeutics, Inc. of Sugar Land, TX. Get the latest business insights from Dun & Bradstreet.See details»
Tvardi Therapeutics - Crunchbase Company Profile & Funding
Tvardi Therapeutics is a Private, Clinical Stage Biotechnology Company. GlobeNewswire News Room — Tvardi Therapeutics Announces Publication of Results from First-in-Human Study of …See details»
Tvardi Therapeutics Org Chart + Executive Team - The Official Board
The organizational chart of Tvardi Therapeutics displays its 13 main executives including Imran Alibhai, Dan Conn, Jeffrey Larson and Stephen O'BrienSee details»
Tvardi Therapeutics - Craft
Tvardi Therapeutics is a biotechnology company developing medicines for the treatment of cancer, chronic inflammation, and fibrosis. It specializes in producing inhibitors of STAT3, a …See details»
Tvardi Therapeutics - LinkedIn
Tvardi Therapeutics | 2,314 followers on LinkedIn. Breakthrough Medicines for Fibrosis-Driven Diseases | Tvardi is a privately held, clinical-stage, biopharmaceutical company focused on the ...See details»
Investor Relations | Tvardi Therapeutics
Apr 14, 2025 Investor Relations. Tvardi Therapeutics, Inc. is a clinical-stage, biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 …See details»
Tvardi Therapeutics - VentureRadar
Website: https://tvarditherapeutics.com. Develops breakthrough medicines for diverse cancers, chronic inflammatory diseases, and fibrotic diseases through clinical stage, private …See details»
Board of Directors - Tvardi Therapeutics
Prior to her role at Ontada, Dr. Shiff was a Senior Vice President at Merck & Co, and Head of the Center for Observational and Real-World Evidence, an organization that lead the …See details»
Tvardi Therapeutics - PitchBook
Tvardi Therapeutics General Information Description. Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule …See details»
Tvardi Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Tvardi Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 27 news, and 1 literature, Disease Domain ...See details»
Tvardi Therapeutics - LifeScienceHistory.com
Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases, and fibrotic …See details»
Tvardi Therapeutics — Catalytic Impact Foundation
CEO: Imran Alibhai. Visit Website. Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic …See details»
Tvardi Therapeutics Raises $74 Million in Series B Financing
Jun 23, 2021 Tvardi Therapeutics, Inc. (“Tvardi”) a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, has closed a …See details»
FDA Grants Fast Track Designation to Tvardi Therapeutics’ TTI-101 …
FDA Grants Fast Track Designation to Tvardi Therapeutics’ TTI-101 for Hepatocellular Carcinoma. Oct 27, 2022 | Press Releases. Houston, TX – October 19, 2022 – Tvardi …See details»
Tvardi Therapeutics - Overview, News & Similar companies
Feb 29, 2024 Tvardi Therapeutics to Participate at the Cowen 44th Annual Health Care Conference HOUSTON--(BUSINESS WIRE)-- #HCC--Tvardi Therapeutics, Inc. (“Tvardi”), a …See details»